The primary amino acid sequences of the mutated peptides with variants at the fifth residue were listed with the inhibition rate at a fixed concentration of 1 μM. Those with > 90% inhibition were further characterized for IC50
 | |||
|---|---|---|---|
| Name | Amino acid sequence | Inhibition (%) | IC50 ± SD (nM) |
| BCP-16B | Ala-Cys-Ala-Gly-Arg-Cys-Gly-Ser-Ala-Cys-Leu | 95.8% | 116.67 ± 7.79 nM |
| BCP-17B | Ala-Cys-Ala-Gly- | 75.4% | - |
| BCP-18B | Ala-Cys-Ala-Gly- | 71.2% | - |
| BCP-19B | Ala-Cys-Ala-Gly- | 96.8% | 100.74 ± 16.29 nM |
| BCP-20B | Ala-Cys-Ala-Gly- | 80.1% | - |
| BCP-21B | Ala-Cys-Ala-Gly- | 67.4% | - |
| BCP-22B | Ala-Cys-Ala-Gly- | 99.3% | 79.15 ± 4.36 nM |
| BCP-23B | Ala-Cys-Ala-Gly- | 64.7% | - |
-: no data. SD: standard deviation; IC50: half-maximal inhibitory concentration